Trial intelligence / Profile preview

Kuanxiong Aerosol for angina after coronary intervention

ChiCTR1900027006Phase 4Recruiting

Sponsor
Guangdong Provincial Hospital of Traditional Chinese Medicine
Start
May 2019
Countries
1
01

Overview

Phase 4, open-label trial of kuanxiong aerosol in angina pectoris (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Seattle Angina Questionnaire. Started May 2019; status: recruiting.

02

Drugs

kuanxiong aerosol
03

Conditions

angina pectoris

Beyond the preview

Go deeper on ChiCTR1900027006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900027006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call